Đang chuẩn bị liên kết để tải về tài liệu:
Obesity and breast cancer outcomes in chemotherapy patients in New Zealand – a population-based cohort study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Obesity has been reported as an adverse prognostic factor in breast cancer, but inconsistently, and under-treatment with chemotherapy may occur. We provide the first assessment of obesity and breast cancer outcomes in a population-based, multi-ethnic cohort of New Zealand patients treated with chemotherapy. | Obesity and breast cancer outcomes in chemotherapy patients in New Zealand a population-based cohort study

TÀI LIỆU LIÊN QUAN

Phase II study of metformin for reduction of obesity-associated breast cancer risk: A randomized controlled trial protocol

Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on breast and colorectal cancer risk among postmenopausal women

Obesity and breast cancer outcomes in chemotherapy patients in New Zealand – a population-based cohort study

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression

Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients

Báo cáo khoa học: Ablation of Sax2 gene expression prevents diet-induced obesity

Báo cáo khoa học: Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity

Báo cáo khoa học: Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases

Obesity as risk factor for subtypes of breast cancer: Results from a prospective cohort study

Obesity impacts the regulation of miR-10b and its targets in primary breast tumors
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.